Specialised Surgical Management of Pseudomyxoma Peritonei
Pseudomyxoma Peritonei is a rare and complex clinical condition characterized by the progressive accumulation of mucinous fluid within the abdominal cavity. This condition most frequently originates from a ruptured appendiceal mucocele or a low grade mucinous neoplasm of the appendix.
As the tumor cells redistribute throughout the peritoneum, they produce a thick, jelly like substance that eventually compresses the abdominal organs. Because of the unique biological nature of these mucinous tumors, standard systemic chemotherapy often fails to penetrate the disease site effectively.
Dr. Snita Sinukumar provides a specialized multi modality approach that combines extensive Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to physically eliminate the tumor burden and target residual microscopic disease.
Classification of PMP and Appendiceal Tumors
Not all mucinous tumors are identical. The management strategy depends heavily on the pathological subtype of the primary tumor. Our team works closely with specialized onco pathologists to classify the disease according to current international standards:
- Low Grade Appendiceal Mucinous Neoplasm (LAMN): These are slow growing tumors with a relatively favorable prognosis if treated with complete cytoreduction.
- High Grade Appendiceal Mucinous Neoplasm (HAMN): These tumors exhibit more aggressive cellular features and require meticulous surgical clearance and intensive follow up.
- Mucinous Adenocarcinoma: A more aggressive form of the disease that may require a combination of systemic chemotherapy and radical surgery.
- Peritoneal Carcinomatosis (DPAM vs PMCA): Differentiating between disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis is critical for determining long term survival outcomes.
The Peritoneal Cancer Index (PCI)
Before proceeding with surgery, the PCI score is calculated using high resolution imaging. This score is the primary roadmap for the surgical team, dividing the abdomen into 13 regions to quantify the tumor burden.
A lower PCI score typically indicates a higher probability of achieving a Complete Cytoreduction (CC-0), where no visible tumor remains. For PMP patients in Pune, accurate PCI assessment is the cornerstone of successful surgical planning and provides a realistic outlook on recovery.
Advanced Peritonectomy Procedures
The definitive surgical treatment for PMP involves advanced peritonectomy procedures for the systematic removal of the peritoneal lining. Depending on the disease extent, one or a combination of the following is performed:
- Right Hemicolectomy and Omentectomy
- Splenectomy and Distal Pancreatectomy if involved
- Pelvic peritonectomy and resection of reproductive organs in women
- Diaphragmatic stripping to remove tumor deposits from the upper abdomen
Heated Chemotherapy (HIPEC) for PMP
Following the 8 to 12 hour surgical cytoreduction, HIPEC is administered to destroy microscopic cancer cells that the surgeon cannot see. The chemotherapy solution is heated to 42 degrees Celsius to increase the sensitivity of the tumor cells to the drugs.
This localized treatment delivers a high dose of chemotherapy directly to the abdomen while sparing the rest of the body from the severe side effects of systemic chemotherapy. This is particularly effective for PMP because it bypasses the mucinous barrier that otherwise protects the tumor cells.
Post-Operative Recovery and Long Term Surveillance
Recovery after PMP surgery is a gradual process. Most patients remain in the hospital for 10 to 14 days for close monitoring. Because PMP has a risk of recurrence even after successful surgery, Dr. Snita Sinukumar emphasizes a strict long term surveillance protocol:
- Tumor Marker Monitoring: Regular testing of CEA, CA-125, and CA 19-9 levels.
- Serial Imaging: Contrast enhanced CT scans every 3 to 6 months in the initial years post surgery.
- Nutritional Support: Specialized dietary guidance to support bowel health and overall recovery.
- Early Intervention: Immediate evaluation of any new abdominal symptoms to ensure early detection of recurrence.
Dedicated PMP Surgical Oncology in Pune
Dr. Snita Sinukumar is among the few surgeons in India with extensive fellowship training specifically in Peritoneal Surface Oncology and HIPEC.
- Successful management of complex, high volume PMP cases
- Specialized expertise in advanced peritonectomy procedures
- Multidisciplinary care at Apollo Hospitals Pune and Kharadi
- Focus on achieving a high quality of life post extensive cancer surgery